Side-by-side comparison of AI visibility scores, market position, and capabilities
Industrial automation leader transformed by Copeland HVAC divestiture ($14B) and NI test equipment acquisition ($8.2B, 2023); $17.5B FY2024 revenue; 55% AspenTech stake for industrial AI optimization.
Emerson Electric is a leading global technology and software company focused on industrial automation, process control, and test and measurement solutions, founded in 1890 in Ferguson, Missouri and now headquartered in St. Louis, Missouri, trading on NYSE (EMR). The company generated approximately $17.5 billion in revenues for fiscal year 2024 (ending September 30) under CEO Lal Karsanbhai, who has executed the most dramatic portfolio transformation in Emerson's 130-year history: divesting the InSinkErator and Therm-O-Disc consumer and commercial products businesses, selling a 55% stake in Copeland (HVAC compressors) for $14 billion to create a stand-alone entity, and acquiring National Instruments Corporation (NI) for $8.2 billion in 2023—adding NI's LabVIEW test automation software, PXI modular instruments, and automated test equipment platform to create a differentiated test and measurement capability.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.